Process View
Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to oxidative stress.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "negative regulation of cellular response to oxidative stress"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
TRIB3 | tribbles homolog 3 (Drosophila) | 0.978 | ||
SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.718 | ||
RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.693 | ||
MAFG | v-maf musculoaponeurotic fibrosarcoma oncogene homolog G (avian) | 0.646 | ||
ZNF746 | zinc finger protein 746 | 0.426 | ||
NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 | 0.331 | ||
KAT2B | K(lysine) acetyltransferase 2B | 0.328 | ||
SOD1 | superoxide dismutase 1, soluble | 0.319 | ||
GAS6 | growth arrest-specific 6 | 0.291 | ||
KEAP1 | kelch-like ECH-associated protein 1 | 0.260 | ||
PRDX1 | peroxiredoxin 1 | 0.212 | ||
MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.207 | ||
EGLN1 | egl nine homolog 1 (C. elegans) | 0.205 | ||
CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.175 | ||
SQSTM1 | sequestosome 1 | 0.162 | ||
VHL | von Hippel-Lindau tumor suppressor | 0.132 | ||
LAT | linker for activation of T cells | 0.113 | ||
HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 0.113 | ||
SFPQ | splicing factor proline/glutamine-rich | 0.112 | Human | |
TOP1 | topoisomerase (DNA) I | 0.110 | ||
WBP4 | WW domain binding protein 4 (formin binding protein 21) | 0.108 | ||
PINK1 | PTEN induced putative kinase 1 | 0.107 | ||
FBXO7 | F-box protein 7 | 0.099 | ||
HSPB8 | heat shock 22kDa protein 8 | 0.091 | ||
FTH1 | ferritin, heavy polypeptide 1 | 0.087 | ||
RANBP9 | RAN binding protein 9 | 0.086 | ||
PLXNB1 | plexin B1 | 0.084 | ||
CRYAB | crystallin, alpha B | 0.081 | ||
BAG3 | BCL2-associated athanogene 3 | 0.074 | ||
GAB1 | GRB2-associated binding protein 1 | 0.070 | ||
APOE | apolipoprotein E | 0.066 | ||
EFTUD2 | elongation factor Tu GTP binding domain containing 2 | 0.061 | ||
ARNT | aryl hydrocarbon receptor nuclear translocator | 0.053 | ||
CSNK1A1 | casein kinase 1, alpha 1 | 0.052 | ||
DDIT3 | DNA-damage-inducible transcript 3 | 0.051 | ||
DAXX | death-domain associated protein | 0.051 | ||
CTSD | cathepsin D | 0.049 | ||
RUNX1 | runt-related transcription factor 1 | 0.049 | ||
MAP2K5 | mitogen-activated protein kinase kinase 5 | 0.046 | ||
HGF | hepatocyte growth factor (hepapoietin A; scatter factor) | 0.045 | ||
ARHGEF7 | Rho guanine nucleotide exchange factor (GEF) 7 | 0.041 | ||
NONO | non-POU domain containing, octamer-binding | 0.037 | ||
PARK2 | parkinson protein 2, E3 ubiquitin protein ligase (parkin) | 0.036 | ||
AHR | aryl hydrocarbon receptor | 0.034 | ||
RAB5B | RAB5B, member RAS oncogene family | 0.032 | ||
HSF1 | heat shock transcription factor 1 | 0.029 | ||
HDAC1 | histone deacetylase 1 | 0.028 | ||
HNRNPA1 | heterogeneous nuclear ribonucleoprotein A1 | 0.027 | ||
LAMP1 | lysosomal-associated membrane protein 1 | 0.027 | ||
DYNLL1 | dynein, light chain, LC8-type 1 | 0.026 | ||
FUS | fused in sarcoma | 0.026 | ||
PSPC1 | paraspeckle component 1 | 0.025 | Human | |
PML | promyelocytic leukemia | 0.025 | ||
NFE2L1 | nuclear factor (erythroid-derived 2)-like 1 | 0.024 | Human | |
SMAD2 | SMAD family member 2 | 0.023 | ||
MAP1LC3B | microtubule-associated protein 1 light chain 3 beta | 0.023 | ||
GRN | granulin | 0.022 | ||
SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.022 | ||
RCC1 | regulator of chromosome condensation 1 | 0.021 | ||
TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.021 | ||
PTMA | prothymosin, alpha | 0.021 | ||
BACH1 | BTB and CNC homology 1, basic leucine zipper transcription factor 1 | 0.021 | Human | |
SDCBP | syndecan binding protein (syntenin) | 0.021 | ||
EIF2S3 | eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa | 0.020 | ||
APOA1 | apolipoprotein A-I | 0.020 | ||
APOH | apolipoprotein H (beta-2-glycoprotein I) | 0.020 | ||
PRKCZ | protein kinase C, zeta | 0.020 | ||
MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | 0.019 | ||
MAP1B | microtubule-associated protein 1B | 0.019 | ||
IFNAR2 | interferon (alpha, beta and omega) receptor 2 | 0.018 | ||
TPP1 | tripeptidyl peptidase I | 0.018 | ||
GAA | glucosidase, alpha; acid | 0.018 | ||
SIN3A | SIN3 homolog A, transcription regulator (yeast) | 0.018 | ||
MYC | v-myc myelocytomatosis viral oncogene homolog (avian) | 0.017 | ||
PPIA | peptidylprolyl isomerase A (cyclophilin A) | 0.017 | ||
CTSA | cathepsin A | 0.016 | ||
CTSL1 | cathepsin L1 | 0.015 | ||
PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.015 | ||
APLP2 | amyloid beta (A4) precursor-like protein 2 | 0.015 | ||
NAMPT | nicotinamide phosphoribosyltransferase | 0.015 | ||
ZBED1 | zinc finger, BED-type containing 1 | 0.015 | ||
MAP2K6 | mitogen-activated protein kinase kinase 6 | 0.014 | ||
PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.014 | ||
PACRG | PARK2 co-regulated | 0.014 | ||
TOPORS | topoisomerase I binding, arginine/serine-rich, E3 ubiquitin protein ligase | 0.014 | ||
OS9 | osteosarcoma amplified 9, endoplasmic reticulum lectin | 0.014 | ||
CRYAA | crystallin, alpha A | 0.013 | ||
EGLN3 | egl nine homolog 3 (C. elegans) | 0.013 | ||
HNRNPM | heterogeneous nuclear ribonucleoprotein M | 0.013 | ||
RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.013 | ||
HSPB7 | heat shock 27kDa protein family, member 7 (cardiovascular) | 0.013 | ||
BANP | BTG3 associated nuclear protein | 0.013 | ||
CTSB | cathepsin B | 0.013 | ||
PLD3 | phospholipase D family, member 3 | 0.012 | ||
EPAS1 | endothelial PAS domain protein 1 | 0.012 | Human | |
DNMT3B | DNA (cytosine-5-)-methyltransferase 3 beta | 0.012 | ||
MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | 0.012 | ||
ETF1 | eukaryotic translation termination factor 1 | 0.012 | ||
FOXO3 | forkhead box O3 | 0.012 | ||
NBN | nibrin | 0.012 | ||
MAFK | v-maf musculoaponeurotic fibrosarcoma oncogene homolog K (avian) | 0.012 | ||
TIMP2 | TIMP metallopeptidase inhibitor 2 | 0.011 | ||
POMP | proteasome maturation protein | 0.011 | ||
OTUD4 | OTU domain containing 4 | 0.011 | ||
TGIF1 | TGFB-induced factor homeobox 1 | 0.011 | ||
BCL6 | B-cell CLL/lymphoma 6 | 0.011 | ||
FTL | ferritin, light polypeptide | 0.011 | ||
INSR | insulin receptor | 0.011 | ||
NDUFA4 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4, 9kDa | 0.011 | ||
TSC22D4 | TSC22 domain family, member 4 | 0.011 | ||
UBASH3B | ubiquitin associated and SH3 domain containing B | 0.011 | ||
PLAUR | plasminogen activator, urokinase receptor | 0.011 | ||
MEF2C | myocyte enhancer factor 2C | 0.011 | ||
HPR | haptoglobin-related protein | 0.011 | ||
ATP6AP1 | ATPase, H+ transporting, lysosomal accessory protein 1 | 0.011 | ||
DYNLT1 | dynein, light chain, Tctex-type 1 | 0.010 | ||
SPRY4 | sprouty homolog 4 (Drosophila) | 0.010 | ||
IRS1 | insulin receptor substrate 1 | 0.010 | ||
CHPF | chondroitin polymerizing factor | 0.010 | ||
HSPB2 | heat shock 27kDa protein 2 | 0.010 | ||
ORM1 | orosomucoid 1 | 0.010 | ||
LAMB2 | laminin, beta 2 (laminin S) | 0.010 | ||
SIAH1 | seven in absentia homolog 1 (Drosophila) | 0.010 | ||
NFATC2 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 | 0.010 |